Project Grant HT94252510913
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $2,011,109.00 to Cryocrate LLC, a for-profit limited liability company based in Columbia, Missouri, to develop and secure FDA clearance for their novel cryopreservation technology, Odinsol. The key objectives are to establish GMP production capabilities and conduct in vitro and in vivo evaluations to demonstrate the biocompatibility and...
- This Project Grant award of $2,234,452.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), supports research by the Henry M. Jackson Foundation for the Advancement of Military Medicine to develop a novel cryopreservation strategy for human red blood cells. The goal is to mitigate donor variability and oscillations in mosquito infectivity during controlled human malaria studies. The research project will be conducted from August 15, 2025...
- The Regents of the University of California, San Francisco (UCSF) received a $550,000 Project Grant award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop an advanced cryopreservation system for complex bioengineered tissues. The project aims to determine the thermodynamic and biological parameters needed for isochoric supercooling cryopreservation of three-dimensional tissues within a microgravity-optimized...
- This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $306,852 to Mitegen, LLC, a manufacturer of advanced scientific instruments and technologies located in Lansing, New York. The funding will support the development and validation of innovative cryopreservation technology that automates the soaking, cooling, and warming processes for small biological samples such as oocytes and...
- The Defense Health Agency awarded a $1,999,869 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Hennepin Healthcare Research Institute (HHRI) in Minneapolis, MN. The funding supports the "FROSTBITE MULTICENTER OBSERVATIONAL TRIAL (FROST)" study, which aims to improve health outcomes for military service members and the general public by advancing research on conditions like frostbite. HHRI, a non-profit research organization, will serve...
- The federal Project Grant award of $1,851,874.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public, with a particular emphasis on conditions relevant to military personnel and veterans. The primary awardee, The Henry M. Jackson Foundation for the Advancement of Military Medicine,...
- This federal Project Grant award, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research on extended limb stasis in the Encore Tissue Preservation Device. The $818,337 award, dated August 15, 2025, with a completion date of August 14, 2027, was granted to Vascular Perfusion Solutions Inc. to conduct this biomedical research. The project aims to investigate innovative medical solutions that address critical health...
- The Defense Health Agency awarded a $487,765 Project Grant to The Johns Hopkins University under the Military Medical Research and Development program (CFDA 12.420) to develop "A NOVEL DIGITAL TWIN FOR OPTIMIZING NORMOTHERMIC VCA PRESERVATION". This 3-year research project, with a period of performance from September 30, 2025 to September 29, 2028, aims to advance biomedical research and innovation in healthcare solutions for military service members and the public. The Military...
- This federal Project Grant award, valued at $1,593,795.00 and awarded on July 15, 2025, supports the "Exploration of Topical Amniotic Membrane of the Treatment of Ocular Chemical and Thermal Burn Injuries" research project. The grant was awarded by the Defense Health Agency, which administers the Military Medical Research and Development program (CFDA 12.420). The research is being conducted by the University of Illinois, a prominent public research institution in Chicago, Illinois....
- The U.S. Defense Health Agency awarded a $316,250 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to Coddle Creek Capital, LLC (UEI: S45DEW7HD1T8) located in Kannapolis, NC. The grant, with a performance period from February 1, 2025 to January 31, 2027, will support research on a new class of neurosteroids known as steroid phosphodiesters (SPEDs). The overall goal of this research is to transform healthcare for military service members, veterans, and the...
The Defense Health Agency awarded Cryocrate LLC a $712,461 Project Grant on September 15, 2025 under the Military Medical Research and Development program (CFDA 12.420) to develop advanced biocompatible cryopreservation techniques for eyelid and periorbital tissues. Cryocrate, a for-profit company based in Columbia, Missouri, specializes in innovative cryopreservation solutions for medical and cellular applications. This grant supports Cryocrate's efforts to revolutionize the storage and preservation of biological materials, including through their proprietary cryopreservation medium called Odinsol. The project aims to advance specialized cryopreservation capabilities for various medical domains, with a focus on enabling the clinical implementation of these technologies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $712.5k | 8/18/25 |